amisulpride and its Impurities
Amisulpride is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Reference standards of Amisulpride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


Ethyl (4-(((1-ethylpyrrolidin-2-yl)methyl)carbamoyl)-2-(ethylsulfonyl)-5-methoxyphenyl)carbamate
Ethyl (4-(((1-ethylpyrrolidin-2-yl)methyl)carbamoyl)-2-(ethylsulfonyl)-5-methoxyphenyl)carbamate
Catalogue No.:PA 01 46590
CAS :
NA
Molecular Formula : C20H31N3O6S
Molecular Weight : 441.54